4EASO potently diminished eIF4E protein levels, repressed cap-dependent complex formation, selectively reduced eIF4E regulated proteins (ODC and Bcl-2), reduced mesothelioma cell viability, induced apoptosis, and sensitized mesothelioma cells to gemcitabine and pemetrexed. The gene discussed is EIF4E; the disease is mesothelioma.